{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:23:38Z","timestamp":1748600618408},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,2,28]]},"DOI":"10.18632\/aging.202488","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T10:12:24Z","timestamp":1613038344000},"page":"5607-5620","source":"Crossref","is-referenced-by-count":9,"title":["Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer"],"prefix":"10.18632","volume":"13","author":[{"given":"Jianwen","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunlun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruo","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Medical College of Zhengzhou University, Zhengzhou 450052, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlong","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China"},{"name":"Key Laboratory of Digestive Organ Transplantation of Henan Province, Open and Key Laboratory of Hepatobiliary and Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities, Zhengzhou Key Laboratory of Hepatobiliary and Pancreatic Disease and Organ Transplantation, Zhengzhou 450052, Henan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/CLEP.S37357","article-title":"Gallbladder cancer: epidemiology and outcome.","volume":"6","author":"Shaffer","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017.","volume":"6","author":"Jemal","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","article-title":"Current management of gallbladder carcinoma.","volume":"1","author":"Kooby","year":"2010","journal-title":"Oncologist"},{"key":"4","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.3892\/or.2018.6751","article-title":"Metformin suppresses hypoxiainduced migration via the HIF1alpha\/VEGF pathway in gallbladder cancerand","volume":"4","author":"Zhai","year":"2018","journal-title":"Oncol Rep"},{"key":"5","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1007\/s00268-014-2713-x","article-title":"What is the better choice for T1b gallbladder cancer: simple versus extended cholecystectomy.","volume":"3","author":"Park","year":"2014","journal-title":"World J Surg"},{"key":"6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/0284186X.2017.1418532","article-title":"Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin.","volume":"5","author":"Ten Oever","year":"2018","journal-title":"Acta Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.yexcr.2014.11.021","article-title":"Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1\u03b1.","volume":"33","author":"Wang","year":"2015","journal-title":"Exp Cell Res"},{"key":"8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1159\/000481610","article-title":"CXCR4\/Let-7a axis regulates metastasis and chemoresistance of pancreatic cancer cells through targeting HMGA2.","volume":"4","author":"Yu","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/cas.12652","article-title":"BRCA\/fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer.","volume":"10","author":"Mori","year":"2015","journal-title":"Cancer Sci"},{"key":"10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1158\/1535-7163.MCT-15-0774","article-title":"Expression of GRP78, master regulator of the unfolded protein response, increases chemoresistance in pancreatic ductal adenocarcinoma.","volume":"1","author":"Hill","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ijc.27994","article-title":"AKT inhibition mitigates GRP78 (glucose-regulated protein) expression and contribution to chemoresistance in endometrial cancers.","volume":"13","author":"Lin","year":"2013","journal-title":"Int J Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.7150\/jca.35362","article-title":"High expression of calreticulin indicates poor prognosis and modulates cell migration and invasion via activating Stat3 in nasopharyngeal carcinoma.","volume":"1","author":"Zhou","year":"2019","journal-title":"J Cancer"},{"key":"13","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1158\/1078-0432.CCR-14-0583","article-title":"Calreticulin promotes migration and invasion of esophageal cancer cells by upregulating neuropilin-1 expression via STAT5A.","volume":"2","author":"Wang","year":"2014","journal-title":"Clin Cancer Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1158\/0008-5472.CAN-15-1142","article-title":"Calreticulin expression in human non-small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis.","volume":"7","author":"Dieu-Nosjean","year":"2016","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/jcp.24519","article-title":"Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.","volume":"22","author":"Li","year":"2014","journal-title":"J Cell Physiol"},{"key":"16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13000-015-0382-1","article-title":"Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells.","volume":"1","author":"Zhai","year":"2015","journal-title":"Diagn Pathol"},{"key":"17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3760\/cma.j.issn.0376-2491.2016.10.004","article-title":"[Relationship between the expression of immunoglobulin heavy chain binding protein and calreticulin and metastasis in hepatocellular carcinoma].","volume":"9","author":"Feng","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"18","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms.","volume":"36","author":"Bagienski","year":"2013","journal-title":"N Engl J Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1038\/leu.2014.100","article-title":"Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value.","volume":"2","author":"Guglielmelli","year":"2014","journal-title":"Leukemia"},{"key":"20","doi-asserted-by":"publisher","first-page":"e3147","DOI":"10.1038\/cddis.2017.547","article-title":"Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via integrin\/EGFR-ERK\/MAPK signaling pathway.","volume":"8","author":"Ding","year":"2017","journal-title":"Cell Death Dis"},{"key":"21","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1016\/j.bbamcr.2014.06.017","article-title":"Loss of calreticulin function decreases NF\u03baB activity by stabilizing I\u03baB protein.","volume":"184","author":"Mesaeli","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"22","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1038\/onc.2009.237","article-title":"Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.","volume":"2","author":"Wang","year":"2009","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"publisher","first-page":"e1177692","DOI":"10.1080\/2162402X.2016.1177692","article-title":"Calreticulin expression: interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer.","volume":"5","author":"Kroemer","year":"2016","journal-title":"Oncoimmunology"},{"key":"24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000362978","article-title":"Cell-cell communication in the tumor microenvironment, carcinogenesis, and anticancer treatment.","volume":"3","author":"Jamall","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.semcancer.2017.11.008","article-title":"Matrix metalloproteinases: a challenging paradigm of cancer management.","volume":"5","author":"Rathinavelu","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2015.01.041","article-title":"Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.","volume":"36","author":"Shu","year":"2015","journal-title":"Cancer Lett"},{"key":"27","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1021\/acs.jproteome.5b00794","article-title":"Identification of up- and down-regulated proteins in pemetrexed-resistant human lung adenocarcinoma: flavin reductase and calreticulin play key roles in the development of pemetrexed-associated resistance.","volume":"1","author":"Chan","year":"2015","journal-title":"J Proteome Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000480473","article-title":"CNTN-1 enhances chemoresistance in human lung adenocarcinoma through induction of epithelial-mesenchymal transition by targeting the PI3K\/Akt pathway.","volume":"4","author":"Li","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"29","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/mc.22710","article-title":"Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K\/AKT pathway.","volume":"5","author":"Jia","year":"2017","journal-title":"Mol Carcinog"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T16:18:18Z","timestamp":1617725898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,2,28]]}},"alternative-id":["202488","33591948"],"URL":"https:\/\/doi.org\/10.18632\/aging.202488","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]}}}